Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|GSK3178022||WNT Inhibitor 10||GSK3178022 is an antibody that targets LRP6 and blocks both Wnt binding domains, resulting in decreased Wnt-mediated signaling and potentially leading to decreased tumor growth (PMID: 27401612).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|RSPO3 fusion||colorectal cancer||conflicting||GSK3178022||Preclinical - Pdx||Actionable||In a preclinical study, GSK3178022 inhibited Wnt signaling and delayed tumor growth in a patient-derived xenograft (PDX) model of colorectal cancer harboring an RSPO3 translocation, however, failed to inhibit Wnt signaling or tumor growth in a second RSPO3 translocation-positive colorectal cancer PDX model (PMID: 27401612).||27401612|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|